REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

TCM Biotech International Corp. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: TCM Biotech International Corp. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Established in 1998, TCM Biotech International Corp. is a leading biotech company in Taiwan specializing in innovative research and development of botanic drugs, health food and functional ingredients.

Headquarters
24F-8, No.97, Sec. 1, Xintai 5Th Rd, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the TCM Biotech International Corp. report to view the information.

Website: http://www.tcmbio.com

Basic Information
Total Employees:
Purchase the TCM Biotech International Corp. report to view the information.
Outstanding Shares:
Purchase the TCM Biotech International Corp. report to view the information.
Financial Auditors:
Purchase the TCM Biotech International Corp. report to view the information.
Incorporation Date:
February 20, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Executive Vice President
Ownership Details
Purchase this report to view the information.
15.22%
Purchase this report to view the information.
13.15%
Purchase this report to view the information.
4.23%
Purchase this report to view the information.
0.53%
Purchase this report to view the information.
Subsidiaries
Total Tech Ltd (United States)
100%
Company Performance
Financial values in the chart are available after TCM Biotech International Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-29.08%▼
Total operating revenue
-29.07%▼
Operating profit (EBIT)
-13.56%▼
EBITDA
18.8%▲
Net Profit (Loss) for the Period
16.96%▲
Total assets
48.54%▲
Total equity
92.8%▲
Operating Profit Margin (ROS)
0.52%▲
Net Profit Margin
1.18%▲
Return on Equity (ROE)
-0.61%▼
Debt to Equity Ratio
-11.57%▼
Quick Ratio
3.49%▲
Cash Ratio
2.11%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo